Candel Therapeutics, Inc. (CADL) Operating Lease, Right-of-Use Asset USD 2022 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Candel Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from 2022 to 2024.
  • Candel Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $751 K, a 24.8% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $751 K -$248 K -24.8% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $816 K -$240 K -22.7% Dec 31, 2023 10-Q 2024-05-14
Q3 2023 $879 K -$231 K -20.8% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $940 K -$224 K -19.2% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $999 K -$216 K -17.8% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $1.06 M Dec 31, 2022 10-K 2024-03-28
Q3 2022 $1.11 M Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $1.16 M Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $1.22 M Mar 31, 2022 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.